The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/15936569

Int. J. Radiat. Oncol. Biol. Phys. 2005 Jul 1 62 3 846-53

Download in:

View as

General Info

PMID
15936569